OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00244059

Zhejiang Runtu Co Ltd

Specialty ChemicalsVerified

Zhejiang Runtu maintains a strong liquidity position with a current ratio of 4.73, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's liquidity_fpt score is high, supported by a free cash flow of 842.78 million CNY and a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.02 suggests a conservative capital structure with minimal leverage. In terms of profitability, Zhejiang Runtu reports a return on equity (ROE) of 6.73% and a return on assets (ROA) of 5.79%. These figures are in line with the industry's preferred metrics for profitability, which emphasize ROIC and EBITDA margins. The company's operating income of 809.68 million CNY and net income of 669.36 million CNY reflect a healthy margin profile, although the gross profit of 1.09 billion CNY suggests moderate cost control. Zhejiang Runtu's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment or geographic diversification may expose the company to higher concentration risk, particularly in volatile markets or during supply chain disruptions. The company's growth trajectory is modest, with no significant revenue growth disclosed in the financial snapshot. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, but with a narrow range of price targets (all 14.44 CNY) and no strong buy ratings. The absence of strong buy ratings suggests limited upside potential in the near term. Zhejiang Runtu faces a low dilution risk, with no near-term pressure from share issuance or dilutive events. The company's capital expenditure of -45.72 million CNY indicates a reduction in investment, which may signal a focus on cost optimization rather than expansion. The risk assessment highlights a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. Recent events, including filings and transcripts, are not disclosed in the provided data. However, the company's conservative capital structure and strong liquidity position suggest a stable financial profile, with no immediate signs of distress or aggressive growth strategies.

30-day price · 002440-2.20 (-19.0%)
Low$9.33High$12.84Close$9.37As of22 May, 00:00 UTC
Profile
CompanyZhejiang Runtu Co Ltd
Ticker002440.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Zhejiang Runtu Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. Zhejiang Runtu is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Zhejiang Runtu maintains a strong liquidity position with a current ratio of 4.73, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's liquidity_fpt score is high, supported by a free cash flow of 842.78 million CNY and a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.02 suggests a conservative capital structure with minimal leverage. In terms of profitability, Zhejiang Runtu reports a return on equity (ROE) of 6.73% and a return on assets (ROA) of 5.79%. These figures are in line with the industry's preferred metrics for profitability, which emphasize ROIC and EBITDA margins. The company's operating income of 809.68 million CNY and net income of 669.36 million CNY reflect a healthy margin profile, although the gross profit of 1.09 billion CNY suggests moderate cost control. Zhejiang Runtu's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment or geographic diversification may expose the company to higher concentration risk, particularly in volatile markets or during supply chain disruptions. The company's growth trajectory is modest, with no significant revenue growth disclosed in the financial snapshot. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, but with a narrow range of price targets (all 14.44 CNY) and no strong buy ratings. The absence of strong buy ratings suggests limited upside potential in the near term. Zhejiang Runtu faces a low dilution risk, with no near-term pressure from share issuance or dilutive events. The company's capital expenditure of -45.72 million CNY indicates a reduction in investment, which may signal a focus on cost optimization rather than expansion. The risk assessment highlights a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. Recent events, including filings and transcripts, are not disclosed in the provided data. However, the company's conservative capital structure and strong liquidity position suggest a stable financial profile, with no immediate signs of distress or aggressive growth strategies.
Key takeaways
  • Zhejiang Runtu maintains a strong liquidity position with a current ratio of 4.73 and a low debt-to-equity ratio of 0.02.
  • The company's profitability metrics, including ROE of 6.73% and ROA of 5.79%, are in line with industry standards.
  • Revenue is concentrated in a single business segment, increasing exposure to market volatility.
  • Analysts have assigned a "buy" rating, but with limited upside potential and no strong buy recommendations.
  • The company faces low dilution risk and has reduced capital expenditures, signaling a focus on cost control.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$5.73B
Gross profit$1.09B
Operating income$809.7M
Net income$669.4M
R&D
SG&A
D&A
SBC
Operating cash flow$645.4M
CapEx-$45.7M
Free cash flow$842.8M
Total assets$11.56B
Total liabilities$1.62B
Total equity$9.94B
Cash & equivalents
Long-term debt$247.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.94B
Net cash-$247.3M
Current ratio4.7
Debt/Equity0.0
ROA5.8%
ROE6.7%
Cash conversion96.0%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002440Activity
Op margin14.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin11.7%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin19.1%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity2.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target14.44 CNY
Median price target14.44 CNY
High price target14.44 CNY
Low price target14.44 CNY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.67 CNY
Last actual EPS0.61 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:33 UTCJob: d4d64861